We invite you to partner with us in growing the reach of our breakthrough vision for standardized, effective dog cannabinoid care. Receive wholesale pricing when you share the CHOU2 PHARMA difference with your own valued customers.
Apply now to become one of our select distributors. Our team will reach out via email after your application has been processed.
Sign up. Stay informed. Save.
© Copyright 2022 CHOU2 PHARMA. All Rights Reserved. Privacy Policy. Terms & Conditions.
Cannabinoid products for animals are not yet approved by the FDA Center for Veterinary Medicine. It is advised to consult with a veterinary professional regarding any changes or additions to your dog’s health.
We love pets unconditionally! Give yours the best of the best. Save on your first order & get exclusive offers in the future!
Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.
Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.
A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.
As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.
Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.
Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.
A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.
As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.
